Insmed Total Assets vs Total Debt Analysis

INSM Stock  USD 28.06  0.34  1.23%   
Insmed financial indicator trend analysis is infinitely more than just investigating Insmed Inc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Insmed Inc is a good investment. Please check the relationship between Insmed Total Assets and its Total Debt accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

Total Assets vs Total Debt

Total Assets vs Total Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Insmed Inc Total Assets account and Total Debt. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Insmed's Total Assets and Total Debt is 0.91. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Total Debt in the same time period over historical financial statements of Insmed Inc, assuming nothing else is changed. The correlation between historical values of Insmed's Total Assets and Total Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Insmed Inc are associated (or correlated) with its Total Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Debt has no effect on the direction of Total Assets i.e., Insmed's Total Assets and Total Debt go up and down completely randomly.

Correlation Coefficient

0.91
Relationship DirectionPositive 
Relationship StrengthVery Strong

Total Assets

Total assets refers to the total amount of Insmed assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Insmed Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Major components are Cash and Equivalents; Investments; Goodwill and Intangible Assets; Property Plant and Equipment Net; [TaxAssets] and Trade and Non Trade Receivables.

Total Debt

Total Debt of Insmed Inc is a combination of both Insmed short-term and long-term liabilities. Short-term debts are those that must be paid back within a year. This type of debt applies to things like lines of credit or short-term term bonds. Long-term debt of Insmed Inc includes liability that must be paid off in more than a year. This typically includes large senior debts like mortgages, bonds, as well as business loans or leases. A component of Total Liabilities representing the total amount of current and non-current debt owed. Includes secured and unsecured bonds issued; commercial paper; notes payable; credit facilities; lines of credit; capital lease obligations; operating lease obligations; and convertible notes. Where this item is not contained on the company consolidated financial statements and cannot otherwise be imputed the value of 0 is used.
Most indicators from Insmed's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Insmed Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
At this time, Insmed's Selling General and Administrative Expense is very stable as compared to the past year. As of the 2nd of March 2024, Net Cash Flow Business Acquisitions and Disposals is likely to grow to about 4.2 M, while Net Cash Flow Investment Acquisitions and Disposals is likely to drop (219.4 M).
 2021 2022 2023 2024 (projected)
Interest Expense40.5M26.4M81.7M88.1M
Gross Profit144.3M190.2M239.6M194.8M

Insmed fundamental ratios Correlations

0.950.930.950.920.950.830.870.440.870.870.980.530.49-0.490.880.90.870.860.910.91
0.950.920.950.930.960.820.930.490.930.850.960.620.58-0.590.930.940.930.90.920.95
0.930.920.930.920.90.820.910.550.910.80.940.620.58-0.590.920.950.910.890.840.89
0.950.950.930.990.940.930.910.520.910.880.930.540.49-0.480.920.920.910.880.880.9
0.920.930.920.990.90.950.90.540.90.840.90.50.45-0.440.90.910.90.840.870.87
0.950.960.90.940.90.770.940.420.940.940.970.680.65-0.660.950.950.950.950.850.96
0.830.820.820.930.950.770.740.540.740.720.760.220.17-0.170.740.760.740.670.80.69
0.870.930.910.910.90.940.740.421.00.870.930.790.75-0.761.00.981.00.970.790.96
0.440.490.550.520.540.420.540.420.420.250.440.250.25-0.250.430.530.420.340.610.43
0.870.930.910.910.90.940.741.00.420.870.930.790.75-0.761.00.981.00.970.790.96
0.870.850.80.880.840.940.720.870.250.870.890.630.59-0.580.880.840.880.930.670.87
0.980.960.940.930.90.970.760.930.440.930.890.70.66-0.660.940.950.940.940.880.97
0.530.620.620.540.50.680.220.790.250.790.630.70.99-0.980.790.780.790.820.470.8
0.490.580.580.490.450.650.170.750.250.750.590.660.99-0.990.750.750.750.790.440.77
-0.49-0.59-0.59-0.48-0.44-0.66-0.17-0.76-0.25-0.76-0.58-0.66-0.98-0.99-0.76-0.76-0.76-0.79-0.43-0.76
0.880.930.920.920.90.950.741.00.431.00.880.940.790.75-0.760.991.00.980.80.96
0.90.940.950.920.910.950.760.980.530.980.840.950.780.75-0.760.990.980.960.840.96
0.870.930.910.910.90.950.741.00.421.00.880.940.790.75-0.761.00.980.980.790.96
0.860.90.890.880.840.950.670.970.340.970.930.940.820.79-0.790.980.960.980.710.95
0.910.920.840.880.870.850.80.790.610.790.670.880.470.44-0.430.80.840.790.710.87
0.910.950.890.90.870.960.690.960.430.960.870.970.80.77-0.760.960.960.960.950.87
Click cells to compare fundamentals

Insmed Account Relationship Matchups

Insmed fundamental ratios Accounts

201920202021202220232024 (projected)
Inventories28.3M49.6M67.0M69.9M62.9M51.8M
Receivables19.2M16.6M24.4M29.7M26.7M28.9M
Accounts Payable13.2M42.9M35.8M50.5M45.4M49.0M
Accumulated Other Comprehensive Income(10K)193K968K756K(745K)(764.6K)
Total Assets742.3M796.2M1.2B1.7B1.3B1.1B
Current Assets555.2M622.9M837.0M1.3B929.1M797.6M
Assets Non Current187.1M173.3M406.5M383.1M400.8M432.4M
Cash and Equivalents487.4M532.8M716.8M1.1B482.4M511.2M
Cash and Equivalents USD487.4M532.8M716.8M1.1B482.4M511.2M
Total Debt397.0M404.8M612.3M1.3B1.4B1.5B
Debt Non Current384.8M392.3M602.1M1.3B1.3B1.5B
Total Debt USD397.0M404.8M612.3M1.3B1.4B1.5B
Shareholders Equity Attributable to Parent261.7M275.9M410.5M88.0M(331.9M)(340.7M)
Shareholders Equity USD261.7M275.9M410.5M88.0M(331.9M)(340.7M)
Goodwill and Intangible Assets53.7M49.3M209.9M204.9M199.8M174.2M
Inventory28.3M49.6M67.0M69.9M83.2M73.3M
Total Liabilities480.6M520.3M833.0M1.6B1.7B1.8B
Current Liabilities85.2M118.8M135.2M190.2M225.6M243.4M
Liabilities Non Current395.4M401.5M697.9M1.4B1.4B1.5B
Trade and Non Trade Payables13.2M42.9M125.0M182.1M215.0M232.0M
Property Plant and Equipment Net113.1M97.2M95.5M102.1M104.4M85.2M
Trade and Non Trade Receivables19.2M16.6M24.4M29.7M41.2M34.9M
Accumulated Retained Earnings Deficit(1.5B)(1.8B)(2.3B)(2.7B)(3.4B)(3.5B)

Insmed Investors Sentiment

The influence of Insmed's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Insmed. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Insmed's public news can be used to forecast risks associated with an investment in Insmed. The trend in average sentiment can be used to explain how an investor holding Insmed can time the market purely based on public headlines and social activities around Insmed Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Insmed's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Insmed's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Insmed's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Insmed.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Insmed in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Insmed's short interest history, or implied volatility extrapolated from Insmed options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Insmed Inc is a strong investment it is important to analyze Insmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insmed's future performance. For an informed investment choice regarding Insmed Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Complementary Tools for Insmed Stock analysis

When running Insmed's price analysis, check to measure Insmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insmed is operating at the current time. Most of Insmed's value examination focuses on studying past and present price action to predict the probability of Insmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insmed's price. Additionally, you may evaluate how the addition of Insmed to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Money Managers
Screen money managers from public funds and ETFs managed around the world
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Is Insmed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.34)
Revenue Per Share
2.173
Quarterly Revenue Growth
0.411
Return On Assets
(0.28)
Return On Equity
(14.53)
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.